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ackground: Allgrove syndrome is autosomal recessive disorder, the gene involved in this syndrome is 
known as ALADIN located close to type 2 keratin gene cluster on chromosome 12q13 whose function is 
to control the nucleocytoplasmic trafficking and also affects the nuclear pore complexes. Mutation in 
this gene cause triple A syndrome. The aim of research was to analyze the mutational changes in ALADIN gene, 
formation of 3D Structure of normal and mutated protein and differentiation of normal and mutated protein.  
Method: Genotyping by using tetra arm PCR and Sequence analyses of coding region of ALADIN gene was done 
in two families having affected children with Allgrove syndrome. 
Result: Point mutation in exon 1 and alteration in 3D structure of protein was observed by using VMD (Visual 
molecular dynamics) that shows truncation, absence of few amino acid and structural modification of proteins 
which alters in transportation ability.  
Conclusion: It is concluded from the study that proper structure and function of NPC (nuclear pore complex) 
binding protein is necessary in normal body function and if any mutation is present in ALADIN gene it can 
cause symptoms of rare Allgrove syndrome. 
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Introduction  
Allgrove syndrome or triple A syndrome (AAAS) is a 
hereditary trait acquired with the autosomal recessive 
inheritance which is depicted in a triad of adrenal 
deficiency, alacrima and achalasia. One A refers to 
Achalasia, known as esophageal aperistalsis and damage 
to lower esophageal sphincter (LES) because of loss of 
inhibitory neurons in the esophageal myenteric plexus 
that results in failure of sphincter muscles to relax [1]. 
Achalasia is a disorder that influences the ability to 
move nourishment through the throat, the tube that 
conveys food from the throat to the stomach. It can 
cause extreme nourishing problems and low glucose 
level in body a condition known as hypoglycemia [2]. 
Second A refers to Adrenal deficiency also known as 
Addison disease. Adrenal deficiency occurs when 
adrenal glands do not produce sufficient amount of 
hormone known as cortisol. Cortisol activates the body 
in stress condition. Third A refers to alacrima, which is 
congenital in origin includes a vast range of lacrimal 
secretory disorders. Patients with alacrima show 
complete absence of tears to lower secretion of tears 
(hypolacrima). Alacrima-achalasia disorder with the 
absence of adrenal deficiency is depicted [3]. Adrenal 
deficiency in people with Allgrove syndrome starts in 
younger age but it can also start later in life during their 
30s [4]. Patients with Allgrove syndrome generally show 
hypoglycemia because of adrenal deficiency. Individuals 
with triple A syndrome regularly encounter strange 
sweating, trouble directing pulse, anisocoria, 
dysautonomia, developmental delay, ataxia and 
polyneuropathy with sensory, motor and autonomic 
components, mild dementia and long-tract 
degeneration and parkinsonism [5, 6]. Roubergue et al., 
reported three children with myoclonus of upper limbs 
and face, extensive GIT dysfunction as well as 
dysmotility showing small gall bladder producing small 
bowels [7]. According to Thummler et al., in some 
patient’s medical history is marked by achalasia and 
mega esophagus. Confirmation of Clinical diagnosis is 
done by molecular analysis of the AAAS gene on 
chromosome 12q13 [8]. Allgrove syndrome is diagnosed 
in 100 people worldwide showing autosomal recessive 
pattern of inheritance [9]. Allgrove syndrome was 
considered as an alternative of (FGD) familial 
glucocorticoid deficiency because of appearance of 
ACTH insensitivity in the couple of disorders, while no 
mutation was observed in ACTH receptor gene (18p11.2) 
causing FGD [10]. Weber et al., in 1996 successfully 
located the gene for Allgrove syndrome close to type 2 
keratin gene cluster on chromosome 12q13 [6].  
Handschug et al., in 2001 discovered 16 exons of the 
gene and named it as ALADIN. ALADIN is actually a 
protein performs functions like protein to protein 
interaction, vesicular transportation, RNA 
development, signal transduction, cell division 
management and cytoskeleton assembly includes in a 
section of mammalian NPC (nuclear pore complex). NPC 
is essential in connecting cytoplasm and nucleus of 
different cells. As a result of mutation, ALADIN gene 
dissocialized to cytoplasm instead of NPC, while 
microscopic analysis of Allgrove patients showed that 
triple A syndrome is not a structural disorder at cellular 
level [11, 12]. The genetic map of ALADIN gene is on 
chromosome 12q13, it contains 16 exons and encodes 
547 amino acids located near type II keratin gene 
clusters and some other potential gene are also present 
in nearby region named as SCN8A and HOXC genes [13]. 
In this syndrome, various homozygous and compound 
heterozygous mutations are reported. Most prevalent 
mutation a splice donor mutation IVS14+1G→A is 
observed in all patients. Another prominent novel splice 
donor mutation IVS11+1G→A is observed in exon 11 of 
AAAS patients [14]. Collectively nine different types of 
ALADIN mutations are reported 2 nonsenses, 5-point 
mutations and 2 frameshifts. Four-point mutations are 
observed one is near to the N terminus of ALADIN gene 
while rest of the three is present in the WD-repeat 
domain. Various disease-correlated missense, 
frameshift and nonsense mutations failed to show any 
effect on the structure of Nuclear Pore Complexes 
however functional irregularities are observed.  No 
apparent or visual irregularities of the cores, NPCs and 
nuclear envelopes are observed by analysis of cells taken 
from Allgrove patient [15]. In a Pakistani pedigree 
homozygous nonsense mutation in GMPPA (guanosine 
diphosphate (GDP)-mannose pyro phosphorylase A) 
showed autonomic dysfunction, intellectual disability, 
alacrima, achalasia, gait flaws, and delayed 
development. This autosomal recessive disorder 
depicted resemblance to Allgrove syndrome. It is 
reported that a novel R155P mutation in ALADIN gene 
is linked with Allgrove syndrome and insulin-activated 
hypoglycemia, detected by ACTH stimulation tests [16]. 
Methods  
Collection of blood sample: 
Patients with Allgrove syndrome were identified from 
hospital having clinical data record and 5cc venous 
blood was collected from patient after informed consent 
from parents of patients. Sample were collected in 0.5 M 
EDTA and stored at -4oC until further processed. 
DNA Isolation and Quantification: 
All the samples of Allgrove syndrome patients and 
healthy controls were processed and DNA is isolated by 
using manual techniques and by kit method following 
the manufacturer’s instructions. Isolated DNA samples 
were stored at -20oC or 4oC as required. DNA samples 
were resolved by running the 2% TBE agarose gel along 
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with the standard DNA (DNA of known concentration) 
after mixing with 6X loading dye. Gel was observed 
under ultraviolet light (by using WEALTEC UV-
transilluminator). Quantification was done by 
comparing the intensity of DNA samples with the 
standard. 
Primer designing, PCR and Sequencing: 
Primers of ALADIN gene were designed by software 
primer3. Primers were optimized according to their 
respective melting temperature Tm. For exon 1 (58°C), 
exon 2 (58°C), exon 3 (57°C) exon 4 and 5 (58°C), exon 6 
(56°C), exon 7 (57°C), exon 8 (58°C), exon 9 (56°C), exon 
10 and 11 (57°C), exon 12 and 13 (59°C) exon 14 and 15 
(58.5°C ), exon 16 (57°C). These 16 exon of the ALADIN 
gene were amplified by PCR. The intronic regions 
between the exons 4and 5, 10 and 11, 12 and 13, and 14 
and 15 were small enough to allow these exons to be 
amplified together. PCR was carried out and PCR 
fragments were observed on a 1% agarose gel. Big dye 
terminator cycle sequencing ready reaction Kit was used 
to sequence the PCR products of ALADIN gene. 
Chromatograms from normal and effected individuals 
were compared with the corresponding control gene 
sequence from NCBI to identify the aberrant nucleotide 
base pair change. 
Results 
Sequence analysis: 
The present study involved the sequence analysis of 
coding regions of ALADIN gene in two families having 
affected children with Allgrove syndrome. When the 
sequences of two patient samples were BLAST with 
normal gene sequence present in NCBI a mismatch in 
exon 1 of patient #1 was found (Figure 1). Analysis of 
chromatogram sequence reveal the presence of 
nucleotide A instead of nucleotide G at position number 
128 (figure 2 and 3). This mutation 128G>A was found to 
substitute the threonine with alanine and causes 
immature truncation of mutated protein. Figure 4 shows 
the normal while (Figure 5) shows the mutated protein 
structure. Immature truncation of protein is shown in 
(Figure 6) whole protein is unable to superimposed with 
normal protein, and the sequence of 5aa is missing. In 
the other patient studied no mutation in any exon was 
found. 
Chromatogram file of mutated exon 1 in patient 1: 
The mutated gene has G nucleotide at 128 position of 
exon 1 showing a black peak in sequenced results (Figure 
2). 
Chromatogram file of exon 1 of control sample: 
The normal gene has nucleotide A at 128 positions of 
exon 1 shown by a green peak in sequenced results 
(Figure 3). 
 
Figure 1: BLAST file of mutated and normal ALADIN gene (patient 
#1). 
 
Figure 2: Chromatogram file of mutated exon 1 in patient 1 
 
Figure 3: Chromatogram file of exon 1 of control sample 
3D Structures of protein: 
The 3D structure is obtained by incorporating FASTA 
sequence of ALADIN protein retrieved from NCBI into a 
software PHYRE2. Scenario of this software is web 
entryway for protein displaying, determination and 
examination. By comparing both chromatogram files of 
patient and control it is able to distinguish the peak 
pattern, color change and dimensions. 
3D Structure of ALADIN gene of normal protein (Chain 
A): 
FASTA format of amino acid sequence retrieved from 
NCBI. Here threonine highlighted in greenish normally 
present. 
MCSLGLFPPPPPRGQVTLYEHNNELVTGSSYESPPPDFR
GQWINLPVLQLTKDPLKTPGRLDHGTRTAFIHHREQVW
KRCINIWRDVGLFGVLNEIANSEEEVFEWVKTASGWAL
ALCRWASSLHGSLFPHLSLRSEDLIAEFAQVTNCTIVPSL
KHRLQRNVASLAWKPLSASVLAVACQSCILIWTLDPTSL
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STRPSSGCAQVLSHPGHTPVTSLAWAPSGGRLLSASPVD
AAIRVWDVSTETCVPLPWFRGGGVTNLLWSPDGSKILA
TTPSAVFRVWEAQMWTCERWPTLSGRCQTGCWSPDGS
RLLFTVLGEPLIYSLSFPERCGEGKGCVGGAKSATIVADL
SETTIQTPDGEERLGGEAHSMVWDPSGERLAVLMKGKP
RVQDGKPVILLFRTRNSPVFELLPCGIIQGEPGAQPQLITF
HPSFNKGALLSVGWSTGRIAHIPLYFVNAQFPRFSPVLG
RAQEPPAGGGGSIHDLPLFTETSPTSAPWDPLPGPPPVL
PHSPHSHL 
 
Figure 4: 3D structure of normal protein by PHYRE2 
3D Structure of ALADIN gene of mutated protein (Chain 
B) 
FASTA format of amino acid sequence is retrieved from 
NCBI. Here A (alanine) shown in red is mutated is 
present in place of threonine.  
MCSLGLFPPPPPRGQVTLYEHNNELVAGSSYESPPPDFR
GQWINLPVLQLTKDPLKTPGRLDHGTRTAFIHHREQVW
KRCINIWRDVGLFGVLNEIANSEEEVFEWVKTASGWAL
ALCRWASSLHGSLFPHLSLRSEDLIAEFAQVTNCTIVPSL
KHRLQRNVASLAWKPLSASVLAVACQSCILIWTLDPTSL
STRPSSGCAQVLSHPGHTPVTSLAWAPSGGRLLSASPVD
AAIRVWDVSTETCVPLPWFRGGGVTNLLWSPDGSKILA
TTPSAVFRVWEAQMWTCERWPTLSGRCQTGCWSPDGS
RLLFTVLGEPLIYSLSFPERCGEGKGCVGGAKSATIVADL
SETTIQTPDGEERLGGEAHSMVWDPSGERLAVLMKGKP
RVQDGKPVILLFRTRNSPVFELLPCGIIQGEPGAQPQLITF
HPSFNKGALLSVGWSTGRIAHIPLYFVNAQFPRFSPVLG
RAQEPPAGGGGSIHDLPLFTETSPTSAPWDPLPGPPPVL
PHSPHSHL  
This change in amino acid is manually done using 
FASTA sequence of protein as we know the change by 
sequencing. 
Superimposition of chain A and chain B 
In order to analyze the difference between two chains 
VMD and FATCAT structure alignment software is 
applicable to visualize the structural change between 
them. Most of the structure in Figure 6 showed structure 
alignment except that shown in the box which is a part 
of normal chain A.  For detailed analysis of amino acid 
sequence VMD is used, the sequence viewer showed that 
chain A has 460aa while that of B has 455aa. Figure 7 
showed the amino acid sequence highlighted in yellow 
unable to super imposed with each other, part of chain 
A. Due to this difference of 5aa, some of the part remain 
free from compact globular structure. 
 
Figure 5: 3D structure of mutated protein by PHYRE2 
 
Figure 6: Superimposition of chain A and chain B by VMD 
software 
 
Figure 7: Sequence of amino acids highlighted in yellow by VMD 
software 
Discussion  
Allgrove syndrome is a hereditary trait acquired as an 
autosomal recessive condition which is portrayed in a 
trine of adrenal inadequacy, alacrima and achalasia. 
AAAS is an abbreviated form of Allgrove syndrome. 
Adrenal insufficiency involves inappropriate 
functioning of adrenal glands present in proximal part 
of kidney, alacrima refers to the absence of tears during 
cry of a child because tears secreting glands lose their 
functioning as the transportation of cell is affected that 
propagate tears out of the cell and the last one is 
achalasia that involves the improper functioning of 
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sphincter muscles present on the distal end of 
esophagus and stomach, when food is passed through 
the muscle it is unable to hold that bolus[16, 17]. 
The main focus of the study was to determine 
mutations in coding region of ALADIN that might cause 
this syndrome, the product of ALADIN gene acts as 
subunit of nuclear pore complex involved in 
transportation, role in the formation of mitotic spindle 
during cell division, controls hypoglycemia, in fact it is 
involved in multiple sets of processes. Different types of 
mutations are reported from different regions of world. 
But in this study, we found a point mutation in exon1 
that alters the amino acid sequence in protein 
polypeptide which was not similar in both patients. The 
mutation that is observed in present study was similar 
to the mutation found in an article published in 2009 
that transforms A to G in exon 1 showed ophthalmic 
abnormalities [18]. It was reported that clinical 
diagnosis of Allgrove patients is difficult as it is an 
autosomal recessive trait, secondly unable to know the 
complete history of patients; thirdly different patients 
show only two or more symptoms of this disease. 
Alteration which is observed in protein was the 
modification of its structure that alters the carrying or 
transporting ability of mutated protein. The protein 
structure of both of the patient 1 and control were 
different and are not completely superimposed on each 
other concluding this patient shows different 
morphology of protein structure. The mutated protein 
having point mutation in exon 1 showed the absence of 
5 amino acids in its polypeptide chain and the second 
patient was used as control in order to determine or 
estimate the appeared differences. The results of patient 
2 were different as no mutation in all the exons was 
observed. Similarly, no mutation in ALADIN gene is also 
reported in Allgrove patients showing genotypic 
heterogeneity [19]. It is concluded from the study that 
ALADIN gene should performs its function properly in 
NPC binding which is necessary for normal body 
functioning and if any alteration/ mutation is present in 
ALADIN gene it can cause symptoms of rare disorder 
AAA syndrome. Although further studies are required to 
find actual cause of AAAS. 
In this study found a point mutation in exon1 that 
alters the amino acid sequence in protein which was not 
similar in both patients of triple A syndrome. Findings 
of the present study seem to be interesting and analysis 
on larger cohort needs to be performed to validate the 
results. 
Conflict of Interest Statement 
The authors declare that there is no conflict of interest 
regarding the publication of this paper. 
Authors’ Contribution 
Fezza Arshad performed the experiment and prepared 
figures. Nida Abdul Qadir authored and reviewed draft 
of paper. Nosheen Ishaq performed the experiment. 
Muhammad Aiman Shehzad identified the patients. 
Saqib Mehmood identified the patients. Warda Fatima 
supervised, reviewed and approved the final draft of 
paper. 
References 
1. Gockel HR, Schumacher J, Gockel I, Lang H, Haaf T, et al. 
Achalasia: will genetic studies provide insights? Human Genetics, 
(2010); 128(4): 353-64. 
2. Kunte H, Nümann A, Ventz M, Siebert E, Harms L. Wernicke’s 
encephalopathy in a patient with triple A (Allgrove) syndrome. 
Journal of neurology, (2011); 258(10): 1882-4. 
3. Menon SK, Bangar TR, Kaba A, Shah R, Menon PS, et al. Triple A 
syndrome. Indian Journal Pediatrics, (2008);75(9):967-. 
4. Houlden H, Smith S, de Carvalho M, Blake J, et al. Clinical and 
genetic characterization of families with triple A (Allgrove) 
syndrome. Brain, (2002); 125(12): 2681-90. 
5. Nakamura K, Yoshida K, Yoshinaga T, Kodaira M, Shimojima Y, et 
al. Adult or late-onset triple A syndrome: case report and literature 
review. Journal of the Neurological Sciences, (2010); 297(1): 85-8. 
6. Dumić M, Barišić N, Rojnić-Putarek N, Kušec V, Stanimirović A, et 
al. Two siblings with triple A syndrome and novel mutation 
presenting as hereditary polyneuropathy. European Journal of 
Pediatrics, (2011); 170(3): 393-6. 
7. Roubergue A, Apartis E, Vidailhet M, Mignot C, Tullio‐Pelet A, et 
al. Myoclonus and generalized digestive dysmotility in triple A 
syndrome with AAAS gene mutation. Movement disorders: official 
journal of the Movement Disorder Society, (2004); 19(3): 344-6. 
8. Thümmler S, Huebner A, Baechler-Sadoul E. Triple A syndrome: 
two novel mutations in the AAAS gene. BMJ case reports, (2009): 
bcr0920080984. 
9. Bizzarri C, Benevento D, Terzi C, Huebner A, Cappa M. Triple A 
(Allgrove) syndrome: an unusual association with syringomyelia. 
Italian Journal of Pediatrics, (2013); 39(1): 39. 
10. Clark AJ, Cammas FM, Watt A, Kapas S, Weber A. Familial 
glucocorticoid deficiency: one syndrome, but more than one gene. 
Journal of Molecular Medicine, (1997); 75(6): 394-9. 
11. Weber A, Wienker TF, Jung M, Easton D, Dean HJ, et al. Linkage of 
the gene for the triple A syndrome to chromosome 12q13 near the 
type II keratin gene cluster. Human Molecular Genetics, (1996); 
5(12): 2061-6. 
12. Dixit A, Chow G, Sarkar A. Neurologic presentation of triple A 
syndrome. Turkiye Klinikleri Journal Pediatrics, (2011); 45(5): 347-
9. 
13. Handschug K, Sperling S, Yoon SJ, Hennig S, et al. Triple A 
syndrome is caused by mutations in AAAS, a new WD-repeat 
protein gene. Human Molecular Genetics, (2001); 10(3): 283-90. 
14. Koehler K, Malik M, Mahmood S, Gießelmann S, Beetz C, et al. 
Mutations in GMPPA cause a glycosylation disorder characterized 
by intellectual disability and autonomic dysfunction. The 
American Journal of Human Genetics, (2013); 93(4): 727-34. 
15. Kind B, Koehler K, Krumbholz M, Landgraf D, Huebner A. 
Intracellular ROS level is increased in fibroblasts of triple A 
syndrome patients. Journal of Molecular Medicine, (2010); 88(12): 
1233-42. 
16. Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADINI482S causes 
selective failure of nuclear protein import and hypersensitivity to 
oxidative stress in triple A syndrome. Proceedings of the National 
Academy of Sciences, (2006); 103(7): 2298-303. 
17. Spiegel R, Shalev S, Huebner A, Horovitz Y. Association of chronic 
symptomatic neutropenia with the triple A syndrome. Journal  of 
Pediatrics, hematology/oncology, (2005); 27(1): 53-5. 
                         Advancements in Life Sciences  |  www.als-journal.com  |  November 2019  | Volume 7  |  Issue 1 15                                                          
 
Genotypic and computational sequence analysis of ALADIN gene causing Allgrove syndrome You’re reading 
als 
18. Villanueva-Mendoza C, Martinez-Guzman O, Rivera-Parra D, 
Zenteno JC. Triple A or Allgrove syndrome. A case report with 
ophthalmic abnormalities and a novel mutation in the AAAS gene. 
Ophthalmic Genetics, (2009); 30(1): 45-9. 
19. Palka C, Giuliani R, Brancati F, Mohn A, Di Muzio A, Calabrese O, 
Huebner A, De Grandis D, Chiarelli F, Ferlini A, Stuppia L. Two 
Italian patients with novel AAAS gene mutation expand allelic and 
phenotypic spectrum of triple A (Allgrove) syndrome. Clinical 
Genetics, (2010);77(3):298-301. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative 
Commons Attribution-Non Commercial 4.0 
International License. To read the copy of this 
license please visit:  https://creativecommons.org/licenses/by-
nc/4.0/ 
